Answers are grounded in this paper and cite their sources.
Gray mold, caused by Botrytis cinerea , significantly reduces postharvest tomato quality, and biological control offers a safer and more sustainable alternative to synthetic fungicides. However, the postharvest biocontrol potential of Discosia artocreas remains largely unexplored. In this study, the endophytic fungal strain DY-17 was isolated from the leaves of Drynaria roosii Nakaike and identified as D. artocreas . Dual-culture assays showed that DY-17 inhibited B. cinerea mycelial growth by 83.40 ± 0.61% and exhibited broad-spectrum antifungal activity against 12 additional plant-pathogenic fungi. Scanning electron microscopy revealed that DY-17 caused B. cinerea mycelial abnormalities and inhibited spore production. In vivo experiments confirmed that DY-17 pretreatment effectively reduced gray mold development, decreased B. cinerea accumulation in tomato fruit, and reduced lesion area by 88.0% at 120 h. Whole-genome analysis identified diverse predicted biosynthetic gene clusters, including nonribosomal peptide synthetase, polyketide synthase, terpene, siderophore, and indole clusters, indicating the genetic potential of DY-17 to produce bioactive secondary metabolites. Furthermore, DY-17 pretreatment increased phenylalanine ammonia-lyase, polyphenol oxidase, β-1,3-glucanase, and chitinase activities, and enhanced the expression of defense-related genes SlPR2 and SlPR3 in tomato fruit. Combined transcriptome and metabolome analyses revealed DY-17-associated changes in plant hormone signal transduction, flavonoid and phenylpropanoid metabolism, redox-related metabolism, and organic acid and fatty acid metabolism in tomato. JA/ET-related signaling was a prominent component of these defense-associated responses, while additional hormone-related pathways were also altered. In conclusion, D. artocreas DY-17 suppresses postharvest gray mold through direct antagonism of B. cinerea combined with host defense-associated responses. This study provides a foundation for developing fungal biocontrol agents for the sustainable management of postharvest diseases.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: